ZenGUARD(TM) Enhanced Air Filters to Be Added as Class 1 Medical Device Under Zentek's Medical Device Establishment Licence
-
Woltemade sends Germany past Luxembourg in World Cup qualifier
-
Croatia qualify for 2026 World Cup with 3-1 win over Faroes
-
Kai Trump makes strides but still misses cut in LPGA debut
-
Return to bad days of hyperinflation looms in Venezuela
-
US airspace recovers as budget shutdown ends
-
Russia strike on Kyiv apartment block kills six, Ukraine says
-
Arrest made in shooting of 'Last Chance U' coach: US police
-
At COP30, senator warns US 'deliberately losing' clean tech race with China
-
US, Switzerland say deal reached on trade and tariffs
-
Fossil fuel lobbyists out in force at Amazon climate talks: NGOs
-
Returning Alldritt blames himself for France axing
-
Stocks struggle on US rates, tech rally fears
-
A rare oil CEO shows up at COP30, spars with activists
-
Trump demands probe into Epstein links to Bill Clinton
-
England great Anderson says 'weak' Australia still Ashes favourites
-
Indigenous protesters disrupt UN climate summit again
-
Gun salutes for King Charles III as he marks 77th birthday
-
Ford urges England to make their own New Zealand history
-
Acosta top in Valencia MotoGP practice as Martin returns
-
Michelle Yeoh to get honorary award at Berlin film fest
-
Bulgaria names manager to take over Russia's Lukoil refinery after US sanctions
-
Spain players on their way to becoming 'legendary': coach De la Fuente
-
US, Switzerland say reached deal on trade and tariffs
-
Saudi prince, eyeing defence pledge, to meet Trump after long US absence
-
Water shortage pushes Kyrgyzstan, Tajikistan into energy crisis
-
Sinner completes perfect ATP Finals group stage by seeing off Shelton
-
Darge returns to Scotland starting side against Argentina
-
'Battling' McIlroy closes in on Race to Dubai title
-
Heyes says England need fans' help to seal 'massive' New Zealand win
-
Indigenous protest blocks entrance to UN climate summit
-
Russia strikes on Kyiv apartment blocks kill six, Ukraine says
-
Tanzania president announces inquiry into protest deaths
-
Parker failed drugs test on day of heavyweight defeat - promoter
-
UN rights council orders probe of atrocities in Sudan's El-Fasher
-
Not magic but patience key to Bumrah's bowling masterclass
-
Parker failed drugs test before heavyweight clash with Wardley - promoter
-
Indigenous protest blocks entrance to UN COP30 climate summit
-
Japan beat Ghana in friendly to build World Cup momentum
-
'Time is running out': Serbia eyes winter energy crisis
-
Doctors in England launch strike over pay and jobs
-
Stocks sink on fears over tech rally, US rates
-
Santiago Carreras benched as Pumas ring changes for Scotland
-
Bumrah claims five as India seize advantage in first South Africa Test
-
Thais navigate flooded homes and ancient temples by boat
-
Second brother of French anti-drugs activist murdered: prosecutor
-
O'Neill still uncertain over Celtic future
-
BHP liable for 2015 Brazil mine disaster: UK court
-
Four killed in 'heinous' Russian attack on Ukraine: Zelensky
-
Germany unveils debt-laden budget, relief measures
-
Japan manga powerhouse 'Dragon Ball' launches store
NYSE - LSE
| RBGPF | -3.73% | 75.65 | $ | |
| CMSC | -0.04% | 23.82 | $ | |
| RYCEF | -3.09% | 14.55 | $ | |
| VOD | -0.73% | 12.32 | $ | |
| RIO | -0.58% | 70.63 | $ | |
| SCS | 0.51% | 15.7 | $ | |
| RELX | -0.22% | 41.33 | $ | |
| GSK | -1.15% | 47.18 | $ | |
| NGG | -0.92% | 77.38 | $ | |
| BTI | -0.65% | 54.13 | $ | |
| BP | 1.48% | 36.53 | $ | |
| JRI | 0.1% | 13.65 | $ | |
| CMSD | 0.61% | 23.99 | $ | |
| BCC | -0.2% | 69.04 | $ | |
| AZN | 0.55% | 89.1 | $ | |
| BCE | -1.23% | 22.83 | $ |
ZenGUARD(TM) Enhanced Air Filters to Be Added as Class 1 Medical Device Under Zentek's Medical Device Establishment Licence
Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, announces its decision that its ZenGUARD™ Enhanced Air Filters will be added under the company's existing medical device establishment licence ("MDEL"), similar to ZenGUARD™ Surgical Masks.
Initial test work and validation began on ZenGUARD™ Enhanced Air Filters in early 2021, culminating in the award of an Innovative Solutions Canada ("ISC") Testing Stream.
The purpose of the ISC Testing Stream - The Government of Canada contract awarded in 2021 - was to determine whether ZenGUARD™ Enhanced Air Filters could achieve a significant net reduction in airborne respiratory pathogens, thereby validating it as an effective device to mitigate the transmission of disease.
Independent proof-of-concept testing and validation was completed by the National Research Council of Canada in their unique bioaerosol facility, a purpose-built modular room intended to simulate the risk of infection in a real-world classroom environment. LMS Technologies Inc. was subsequently contracted to test ZenGUARD™ Enhanced Air Filter finished products and reported an average viral filtration efficiency ("VFE") enhancement of ~66% compared to an untreated filter, or an average ~67% VFE under simulated operating conditions over 6 months with negligible change in pressure drop.
This extensive testing program was conducted over the course of approximately two years and successfully demonstrated that ZenGUARD™ Enhanced Air Filters can achieve a significant reduction in airborne respiratory pathogens to help mitigate the transmission of disease indoors.
To further validate this, the Company completed a study with ParticleOne, a RWDI Ventures company. ParticleOne's computational model showcased ZenGUARD™ Enhanced Air Filter's viral filtration action, effectively reducing the spread of viral pathogens and enhancing indoor safety. It also demonstrated potential cost savings from absenteeism related to poor indoor air quality.
Quality Management System
Prior to distributing and selling an additional medical device in Canada, certain testing, process updates and additional documentation related to the Company's supply chain will be required to qualify ZenGUARD™ Enhanced Air Filters as a medical device under its MDEL and ensure compliance with its ISO 13485:2016 Quality Management System. While this process will take additional time and resources, the Company expects it to be significantly less than that required under the previous pathway to market being pursued.
"ZenGUARD™ Enhanced Air Filters will offer a safe and effective way to help prevent the transmission of disease indoors without increasing energy consumption and emissions. This unique value proposition was borne out of an ask from the Government of Canada's Innovation Science and Economic Development agency - and we look forward to fulfilling that ask and helping many others in Canada with a safe and effective technology," said Greg Fenton, CEO of Zentek.
Management Changes
The Company also announces that Nick Hansford, Vice President, Strategy and Product Development, and member of the Zentek management team, has left the company to pursue other opportunities.
About Zentek Ltd.
Zentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development and commercialization of novel products seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener.
Zentek's patented technology platform ZenGUARD™ is shown to have enhanced viral filtration efficiency for surgical masks and aims to do the same for HVAC (heating, ventilation, and air conditioning) systems. Zentek's ZenGUARD™ production facility is in Guelph, Ontario.
For further information on Zentek:
Ryan Shacklock
Senior VP, Strategy & Business Development
Email: [email protected]
Phone: 306-270-9610
To find out more about Zentek, please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at http://www.sedarplus.ca/.
Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Zentek
Y.Aukaiv--AMWN
